CD8A and COVID-19: Furthermore, novel findings suggest a link between prolonged COVID-19 and higher frequencies of fully-functional CD8+ T cells in cancer patients, characterized by a substantial fraction of terminally differentiated effector memory and a lower ratio of central memory T cells [73].